Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

June 17, 2023

Study Completion Date

June 17, 2023

Conditions
DengueDengue With Warning SignsDengue Shock Syndrome
Interventions
DRUG

Montelukast

A 10-mg tablet will be given orally immediately and every day thereafter for 10 days or until recovery, defined as the discontinuation of the follow up appointment by the attending physicians, whichever is shorter

DRUG

Placebo

A 10-mg tablet will be given orally immediately and every day thereafter for 10 days or until recovery, defined as the discontinuation of the follow up appointment by the attending physicians, whichever is shorter

Trial Locations (4)

10400

Phramongkutklao Hospital, Bangkok

15000

Ananda Mahidol Hospital, Lopburi

30000

Fort Suranari Hospital, Nakhon Ratchasima

Unknown

Hatyai Hospital, Hat Yai

All Listed Sponsors
lead

Phramongkutklao College of Medicine and Hospital

OTHER

NCT04673422 - Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients | Biotech Hunter | Biotech Hunter